# Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial

> **NCT06977841** · NA · COMPLETED · sponsor: **Zhongshan Hospital (Xiamen), Fudan University** · enrollment: 640 (actual)

## Conditions studied

- Helicobacter Pylori Eradication
- Adverse Reaction

## Interventions

- **DRUG:** Tegoprazan
- **DRUG:** Amoxicillin
- **DRUG:** Tetracycline
- **DRUG:** Bismuth

## Key facts

- **NCT ID:** NCT06977841
- **Lead sponsor:** Zhongshan Hospital (Xiamen), Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-10
- **Primary completion:** 2026-03-10
- **Final completion:** 2026-03-10
- **Target enrollment:** 640 (ACTUAL)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06977841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06977841, "Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT06977841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*